Contact this trialFirst, we need to learn more about you.
Capmatinib for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
La Jolla, California
This trial will test if adding the drug capmatinib to surgery, chemotherapy, and radiation can improve outcomes for people with early- to mid-stage non-small cell lung cancer that has MET mutations or high MET amplification.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service